2342Trans Genic2342 info
$1.65info0.00%24h
Global rank28388
Market cap$27.78M
Change 7d-8.20%
YTD Performance-9.27%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Trans Genic (2342) Stock Overview

    Trans Genic Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment Business segments. The company provides glycan synthesis and analysis services; non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods, and pharmaceutical agents; and support for bioequivalence test, including clinical trials, pharmacokinetic measurements, and the preparation of clinical trial reports; as well as hospital support services. It also offers drug efficiency and pharmacological test and safety studies; sugar chain analysis and synthesis services; advice and support services, including M&A, business revitalization, business succession services; and contract production services, such as genetically modified mice, antibodies, protein hypers, and expressing cells, as well as sells mouse-related products and mouse models, and research reagents. The company was formerly known as Kumamoto Immunochemical Laboratories Inc. and changed its name to Trans Genic Inc. in April 2000. Trans Genic Inc. was incorporated in 1998 and is headquartered in Fukuoka City, Japan.

    2342 Stock Information

    Symbol
    2342
    Address
    2-3-36 TenjinFukuoka City, 810-0001Japan
    Founded
    -
    Trading hours
    -
    Website
    https://www.transgenic.co.jp
    Country
    🇯🇵 Japan
    Phone Number
    81 9 2288 8470

    Trans Genic (2342) Price Chart

    -
    Value:-

    Trans Genic Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.65
    N/A
    Market Cap
    $27.78M
    N/A
    Shares Outstanding
    16.87M
    N/A
    Employees
    236.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org